A peripheric neuromodulation technique for curing detrusor overactivity: Stoller afferent neurostimulation

Karademir, Kenan; Baykal, Kadir; Şen, Bülent; Şenkul, Temuçin; İşeri, Cüneyt; Erden, Doğan

doi:10.1080/00365590510031147

Cited by 41 publications

(46 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, there were no statistically significant differences in the effects on frequency and urgency between the two groups. [22] Similarly, in our study, the treatment response rate was higher in PTNS+ACD (tolterodine 4 mg SR capsule) group than in PTNS group; however, statistical analysis did not yield a significant difference between the two groups. Literature data and data obtained in our study suggests that we may consider PTNS as a new treatment modality in patients who do not benefit from traditional treatment modalities of OAB; however, simultaneous use of anticholinergic agents does not cause a significant additional benefit even when different agents are used or they are administered for extended periods.…”

Section: Discussionmentioning

confidence: 47%

See 1 more Smart Citation

Role of percutaneous posterior tibial nerve stimulation either alone or combined with an anticholinergic agent in treating patients with overactive bladder

Kızılyel¹,

Karakeçi²,

Ozan³

et al. 2015

Turkish Journal of Urology

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 47%

“…Similar to our study, Karademir et al [22] performed a study on 43 patients, divided them into two groups, and the patients in Group 1 were administered only SANS treatment and the ones in Group 2 were administered SANS+5 mg oxybutynin for 8 weeks. The treatment response rate was 61.6% and 83.2% in Groups 1 and 2, respectively.…”

Section: Discussionmentioning

confidence: 88%

Role of percutaneous posterior tibial nerve stimulation either alone or combined with an anticholinergic agent in treating patients with overactive bladder

Kızılyel¹,

Karakeçi²,

Ozan³

et al. 2015

Turkish Journal of Urology

View full text Add to dashboard Cite

show abstract

“…The responders with positive response of PTNS were also shown in several studies from 2005 to 2006, ranging from 37.3% to 81.8%. [27][28][29][30][31] The terms of responders were more than 50% reduction in symptoms including urgency, frequency, incontinence episodes, 27,29,30 complete recovery after treatment, 28 overall treatment response rate 31 and subjective feeling of improvement. 27 In an RCT by Finazzi Agrò et al 32 comparing PTNS and sham procedure, there were 75% and 0% patients with 50% reduction After its approval by FDA in 2007, PTNS showed considerable promise in the management of OAB.…”

Section: Efficacymentioning

confidence: 99%

Management of overactive bladder review: the role of percutaneous tibial nerve stimulation

Wibisono

Rahardjo

2017

Med J Indones

View full text Add to dashboard Cite

ABSTRAK ABSTRACTOveractive bladder (OAB) is a common condition that is experienced by around 455 million people (11% of the world population) and associated with significant impact in patients' quality of life. The first line treatments of OAB are conservative treatment and anti-muscarinic medication. For the refractory OAB patients, the treatment options available are surgical therapy, electrical stimulation, and botulinum toxin injection. Among them, percutaneous tibial nerve stimulation (PTNS) is a minimally invasive option that aims to stimulate sacral nerve plexus, a group of nerve that is responsible for regulation of bladder function. After its approval by food and drug administration (FDA) in 2007, PTNS revealed considerable promise in OAB management. In this review, several non-comparative and comparative studies comparing PTNS with sham procedure, anti-muscarinic therapy, and multimodal therapy combining PTNS and anti-muscarinic had supportive data to this consideration.

show abstract

“…Six randomized trials provided data on the use of tibial nerve stimulation for treatment of urge urinary incontinence (39)(40)(41)(42)(43)(44). These trials included a total of 426 women, Peters et al had the largest sample analyzing 174 women (39).…”

Section: Tibial Nerve Electrical Stimulationmentioning

confidence: 99%

Electrical Stimulation for Urinary Incontinence in Women: A Systematic Review

et al. 2013

View full text Add to dashboard Cite

Background: Electrical stimulation is commonly recommended to treat urinary incontinence in women. It includes several techniques that can be used to improve stress, urge, and mixed symptoms. However, the magnitude of the alleged benefits is not completely established. Objectives: To determine the effects of electrical stimulation in women with symptoms or urodynamic diagnoses of stress, urge, and mixed incontinence. Search Strategy: Our review included articles published between January 1980 and January 2012. We used the search terms "urinary incontinence", "electrical stimulation", "intravaginal", "tibial nerve" and "neuromodulation" for studies including female patients. Selection Criteria: We evaluated randomized trials that included electrical stimulation in at least one arm of the trial, to treat women with urinary incontinence. Data Collection and Analysis: Two reviewers independently assessed the data from the trials, for inclusion or exclusion, and methodological analysis. Main Results: A total of 30 randomized clinical trials were included. Most of the trials involved intravaginal electrical stimulation. Intravaginal electrical stimulation showed effectiveness in treating urge urinary incontinence, but reported contradictory data regarding stress and mixed incontinence. Tibial-nerve stimulation showed promising results in randomized trials with a short follow-up period. Sacral-nerve stimulation yielded interesting results in refractory patients. Conclusions: Tibial-nerve and intravaginal stimulation have shown effectiveness in treating urge urinary incontinence. Sacral-nerve stimulation provided benefits in refractory cases. Presently available data provide no support for the use of intravaginal electrical stimulation to treat stress urinary incontinence in women. Further randomized trials are necessary to determine the magnitude of benefits, with long-term follow-up, and the effectiveness of other electrical-stimulation therapies.

show abstract

A peripheric neuromodulation technique for curing detrusor overactivity: Stoller afferent neurostimulation

Abstract: SANS is an easy and inexpensive therapeutic method with low morbidity in patients with an overactive bladder. Combination with a low-dose anticholinergic increases the success rate without causing any significant side-effects.

Cited by 41 publications

References 11 publications

Role of percutaneous posterior tibial nerve stimulation either alone or combined with an anticholinergic agent in treating patients with overactive bladder

Role of percutaneous posterior tibial nerve stimulation either alone or combined with an anticholinergic agent in treating patients with overactive bladder

Management of overactive bladder review: the role of percutaneous tibial nerve stimulation

Electrical Stimulation for Urinary Incontinence in Women: A Systematic Review

Contact Info

Product

Resources

About